Fundraising FoxSanofi Ventures — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)inRandall Stanicky(Executive Officer)inAnthony Costello(Director)Bruce Robertson(Director)Douglas Langa(Director)
BoardAlex Zisson(Director)
Board seatCris De Luca· per SEC Form D
Co-investorsAccelmed PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersHealth Catalyst CapitalHikma VenturesRevelation Partners+5 more
Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.
BiotechLongevityMedical DevicesCambridge, US
David Meek(Chief Executive Officer)inBrian Riley(President & Chief Technical Officer)inJoanne Lager(Chief Medical Officer)inWendy DiCicco(Chief Financial Officer)inAdrian Chaisson(Chief of Staff)inJason Cole(Executive Officer)
Co-investorsARCH Venture PartnersEaston CapitalRA CapitalThink+ Ventures Management, LlcWakestream VenturesForbion+1 more
Medisafe is a medication engagement platform that helps pharmaceutical companies connect with patients beyond the prescription and improve treatment adherence.
Digital HealthHealthtechMedical DevicesBoston, US
Rotem Shor(Founder)in
Co-investors7wire VenturesALIVE Israel HealthTech FundCorewell Health VenturesLool VenturesM VenturesOctopus Ventures+3 more
Owkin develops AI Scientist, an autonomous AI system that uses biological large language models and multimodal patient data to accelerate drug discovery for pharmaceutical and biotech companies.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSilicon Valley, FR
Thomas Clozel(Co-founder and Chief Executive Officer)inGilles Wainrib(Co-founder)inThomas Clozel Gilles Wainrib(Founder)
Co-investorsBridford Investments (Bridford Group)Cathay InnovationF-Prime CapitalFrstGV (Google Ventures)Plug and Play Ventures+3 more
Boston-based biotech developing drugs against the 'dark genome'/repeatome for autoimmune disease, cancer and neurodegeneration.
Benjamin Greenbaum(Founder)David Ting(Founder)Rosana Kapeller(Founder)
Co-investorsAndreessen HorowitzARCH Venture PartnersGV (Google Ventures)Luma GroupAbingworthAdvent Life Sciences+11 more
Developing novel treatments based on the 12-LOX pathway for immuno-inflammatory diseases.
Co-investorsAlumni VenturesHatteras Venture PartnersPappas CapitalAlexandriaGenesys CapitalJDRF T1D Fund+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.